MedPath

The effect of modified Constraint-Induced Movement Therapy and dual Transcranial direct current stimulation on the recovery of upper limb function in chronic stroke patients

Not Applicable
Recruiting
Conditions
Diseases of the nervous system
Registration Number
KCT0005478
Lead Sponsor
Young Kwang Hospital
Brief Summary

There were no significant differences in general characteristics and baseline of study subjects between the experimental and the control group. The experimental group and the control group showed significant improvement in FMA and AOU of MAL, Use of unaffected side, and Use of affected side, excluding QOM of MAL. As a result of comparison between groups through ANCOVA, the experimental group showed statistically significant improvement only in the AOU of MAL (p<.05, d=.93) and the Use of unaffected side (p<.05, d=1.07) than the control group. On the other hand, there was no statistical difference in the QOM of MAL and Use of affected side of FMA. However, In effect size Cohen's d, all evaluations including FMA(d=.58), QOM of MAL(d=.28) and use of affected side(d=55) showed a difference in effect size more than small effect.

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients who agreed to participate in the study
Adults aged 20 to 90 and those with chronic stroke (>180 days after onset)
Patients without cognitive impairment with MMSE-K 24 or higher

Exclusion Criteria

Patients who Infarct or hemorrhage in both hemispheres or brainstem areas
Patients who spontaneous stiffness of the joints between the metacarpophalangeal joints and interphalangeal joints is 10° or less and 20° or less, respectively.
Patients who serious damage in balancing or walking
Patients with uncontrolled health conditions or serious terminal illness other than stroke
Patients with severe stiffness in the shoulders, elbows, wrists, or fingers

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Motor Activity Log(MAL);accelerometer;Fugle-Meyer Assessment(FMA)
Secondary Outcome Measures
NameTimeMethod
General characteristics of subjects
© Copyright 2025. All Rights Reserved by MedPath